Pertinent Laboratory Data

Slides:



Advertisements
Similar presentations
Examiner: “A 46 year old woman is referred for a right adrenal mass”
Advertisements

Castrate-resistant prostate cancer (CRPC)
Adrenal Dr Sohail Inam FRCP(Ed), FRCP Consultant Endocrinologist
First Department of Internal Medicine, General Hospital of Rhodes,
A Case From The Clinic Paul J. Scheel, Jr., MD Director Of Nephrology The Johns Hopkins University School of Medicine.
Canadian Cardiovascular Society Antiplatelet Guidelines
Adrenal Gland.
SCLC, Hypertension & Hypokalemia. Is there any correlation?! Wael Batobara.
Pituitary Apoplexy Kyla Lokitz Morning Report 7/18/05.
Cushing’s Syndrome Britni Hebert PGY 2 4/9/10 Notes located in presenter note section below each slide.
PROGRESS NOTE (SOAP Notes)
Recurrent Silent Thyroiditis as a Sequela of Postpartum Thyroiditis Preaw Hanseree, MD, Vincent Salvador, MD, Issac Sachmechi, MD, FACE, Paul Kim, MD,
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 60 Drugs for Disorders of the Adrenal Cortex.
General Medicine Conference “Hirsutism” General Medicine Conference “Hirsutism” Selim Krim, MD Assistant professor Texas Tech University Health Sciences.
Department of Medicine Grand Rounds Clinical Vignette Ilana Bragin January 14 th, 2009 NYU Langone Medical Center Internal Medicine Residency Program.
HIRSUTISM. Definition  Hirsutism Excessive growth of hair in abnormal position on the body  Virilism Masculinization of female i.e. deepening of voice,
13 Lecture Notes Endocrine System
Endocrine System. SymptomsTreatmentTestsGeneral info Recommendation
OST 529 Systems Biology: Endocrinology
Endocrine Physiology: Case Studies in Adrenal Disorders C.W. Spellman, PhD, DO Assoc. Prof. Medicine Assist. Dean, Dual Degree Program Head, Endocrinology.
NYU Medical Grand Rounds Clinical Vignette Lucy Doyle MD, PGY-2 March 24, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Izben C. Williams, MD, MPH Instructor. BIOLOCICAL ASSESSMENT OF PATIENTS WITH PSYCHIATRIC SYMPTOMS.
Clinical Update in Type 2 Diabetes A Case Discussion Dr. Yancey R. Holmes, MD, FACE Ohio Valley Endocrinology.
M Iacobone, G Viel, S Zanella, M Frego, G Favia
OSCE Questions For JCM on 3 Dec Case 1 O F/8 Good past health O She has fever with some URI symptoms for past few days. She starts to complain right.
Hypercortisolism (Cushing’ s Syndrome)
Adult Medical-Surgical Nursing Endocrine Module: Disorders of the Adrenal Cortex: Cushing’s Syndrome.
Cushing’s Syndrome.
NYU Medical Grand Rounds Clinical Vignette NYU Medical Grand Rounds Clinical Vignette Michael Chu MD, PGY-2 5/20/09.
NYU Medical Grand Rounds Clinical Vignette Lisa Cioce MD, PGY-2 March 10, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Adult Medical-Surgical Nursing Endocrine Module: Anterior Pituitary Hypersecretion (ACTH)
This lecture was conducted during the Nephrology Unit Grand Ground by Registrar under Nephrology Division under the supervision and administration of Prof.
NYU Medical Grand Rounds Clinical Vignette Denise Pate MD, PGY-2 January 27, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
71-year old male Admitted with worsening shortness of breath PMHx: Severe COPD, A.Fib, CHF/ischemic, PE On long term anticoagulation with Pradaxa 150.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
Cushing’s Syndrome Stephen Ou R2 May 17, Learning Objectives Discuss the different etiologies of hypercortisolism. Recognize the clinical manifestations.
NYU Medical Grand Rounds Clinical Vignette Jason Feliberti, MD PGY 2 Tuesday, May 22, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
NYU Medical Grand Rounds Clinical Vignette Verity Schaye, MD PGY-3 September 15, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
NYU Medical Grand Rounds Clinical Vignette Rachel Shur PGY-2 October 16, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Cushing’s syndrome. Most common cause of Cushing’s syndrome?
 Chronic (persistent or lasting) medical condition where blood pressure is elevated.  Also referred to as High Blood Pressure (HBP)  The term hypertension.
Evaluation and Management of the Patient with Hypertension and Hypokalemia Stephen L. Aronoff, MD.
Corticosteroids.
Adrenal Glucocorticoids 7 أ. م. د. وحدة بشير اليوزبكي Head of Department of Pharmacology- College of Medicine- University of Mosul-2014.
Date of download: 6/1/2016 From: A Physiologic Approach to Diagnosis of the Cushing Syndrome Ann Intern Med. 2003;138(12): doi: /
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 60 Drugs for Disorders of the Adrenal Cortex.
CEREBROTENDINOUS XANTHOMATOSIS Sheri Harder* Paggie Kim * Miriam Peckham * Teresa LaBarte ŧ Departments of Radiology (Division of Neuroradiology)* and.
Control #: 1509 Excerpta #: EE-47
Mayo Clinic, Jacksonville, FL
Adrenal gland hyperfunction
DOC secreting adrenal adenoma, a rare cause of hypertension
CRT 2012 Venous Disease.
An Unusual Case of Graves’ Disease Coexisting with Struma Ovarii Iqra Javeed MD1, Amin Sabet MD2, and Jacqueline Kung MD1 1Division of Endocrinology, Diabetes,
B. Primary adrenal hyperplasia and neoplasms
Inferior Petrosal Sinus Sampling in Cushing’s Syndrome
Atypical Teratoid Rhabdoid Tumor of the Third Cranial Nerve (AT/RT)
Ambreen Khalil MD, Homer Moutran MD, Cristina Corr PA, Fares Elias MD.
Udayan Bhatt, MD MPH OSU Nephrology
Pre-session Number2 (Trial-2 /// 8July2013)
Adrenal Disorders - Some Common Questions Family Practice Refresher Course April 20, 2017 Janet A. Schlechte, M.D.
Use of Mifepristone for Prevention of Adrenal Insufficiency Following
The Role of Induced Hypertension and Hyperbaric Oxygen Therapy in Moyamoya Disease: A Case Report Smeer Salam, MD; Lisa Pabst, MD; Sushil Lakhani, MD;
MRI Brain Evaluation of brain diseases Stroke
Diseases of the Adrenal gland
Chapter 16 Neurologic Dysfunction and Kidney Disease
Major Hormone Secreting Glands of the Endocrine System
Train-the-Trainer Cases
Train-the-Trainer Cases
Train-the-Trainer Cases
Determining the type of Cushing’s syndrome: Not as hard as it seems
Presentation transcript:

Pertinent Laboratory Data Severe metabolic alkalosis and refractory hypokalemia in a patient with metastatic olfactory neuroblastoma Saurabh Chandan, MD1; John Anderson, DO1; Meredith Ross, MD2; Andjela T. Drincic, MD2 1. Internal Medicine, University of Nebraska Medical Center, Omaha, NE, United States.  2. Diabetes, Endocrinology & Metabolism, University of Nebraska Medical Center, Omaha, NE, United States. The differential diagnosis of hypokalemia and metabolic alkalosis is broad. In a patient with ONB, it is important to consider EAS as a possible cause for these metabolic abnormalities in a patient with weight loss despite steroid therapy. Hypokalemia is present in more than 95% of patients with ectopic ACTH syndrome, and less than 10% of patients with Cushing disease. (5) Hypokalemia in EAS is caused a state of mineralocorticoid excess, caused by cortisol saturation of the 11-beta-hydroxysteroid dehydrogenase.(5) Another key feature of this case is the diagnostic dilemma internists face in establishing diagnosis of EAS in patients already on high dose steroid therapy. This patient was on Dexamethasone 4mg twice daily and had inappropriately elevated ACTH and Cortisol levels, raising suspicion for Cushing’s syndrome. Therefore, an accelerated workup was performed on his follow up admission with a high dose dexamethasone suppression test. It is recommended that steroids be discontinued prior to hypercortisolemia workup, this may not always be possible, based on individual patient care. Therapeutically, Dexamethasone therapy had to be continued to prevent progression of cerebral edema in metastatic disease. The internist must be flexible with dynamic testing in cases with confounding and limiting factors. Pertinent Laboratory Data Learning Objectives Recognizing hypercortisolism from ectopic ACTH production as possible cause of patients presenting with severe metabolic alkalosis and refractory hypokalemia. Establishing diagnosis of Ectopic ACTH Syndrome (EAS) and diagnostic dilemma in patients on high dose oral steroid therapy. Table 1: Admission Laboratory Data Table 2: Adrenal Studies * Patient on 6mg Dexamethasone ** High Dose Dexamethasone Suppression test Case Report Figure 1 71 year old Caucasian male with past medical history significant for essential hypertension, hyperlipidemia and metastatic olfactory neuroblastoma (ONB) previously treated with resection and chemotherapy, presented to the emergency department complaining of worsening leg swelling. Pertinent medication includes Dexamethasone 4 mg twice daily. Review of systems revealed a 30lb weight loss. On exam, vital signs were within normal limits including BP 138/68. Pertinent abnormality includes pitting bilateral lower extremity edema.   He was diagnosed with lower extremity deep venous thrombosis. He was started on therapeutic Low Molecular Weight Heparin. Despite aggressive oral and intravenous electrolyte replacement, his potassium and phosphate levels did not normalize, leading to further work up, which revealed elevated random and post-dexamethasone cortisol and ACTH (Table 2), consistent with EAS. For medical treatment of Cushing’s syndrome, he was started on ketoconazole 200mg BID with dose titration, spironolactone 50mg daily, and Acetazolamide 500 mg BID. High dose dexamethasone was continued for treatment of metastatic disease to the brain and associated cerebral edema. Due to declining health the patient was transitioned to comfort measures. Figure 1: MRI of brain demonstrates bilateral frontal dural enhancing masses, T2 hyperintensity consistent with extensive vasogenic edema and gliosis, and small subdural hemorrhage. ONB is an uncommon malignant neoplasm of the nasal vault, believed to develop from olfactory neuroepithelium. They represents 2-3% of all endonasal tumors.(1,2,3) EAS has been reported in patients with ONB.(4) To the best of our knowledge, this is the 19th reported case. Pacak et al described a case of florid Cushing’s syndrome due to an ACTH-producing ONB found to have marked hypokalemia and significant metabolic alkalosis, similar to our case. (5) Discussion References 1. Butt MI, Olczak SA. Cushing Syndrome Secondary to Ectopic Adrenocorticotropic Hormone Secretion From Recurrent Olfactory Neuroblastoma. The Endocrinologist. 2007; 17:160-161. 2. Arnesen MA, Scheithauer BW, Freeman, S. Cushing’s Syndrome Secondary to Olfactory Neuroblastoma. Ultrastructural Pathology. 1994; 18:61-68. 3. Plasencia YL, Cortes MB, et al. Esthesioneuroblastoma Recurrence Presenting as a Syndrome of Inappropriate Antidiurectic Hormone Secretion. Head and Neck-DOI. 2006; 10.1002;1142-1146. 4. Pacak K et al. Ectopic Cushing’s Syndrome Caused by an Esthesioneuroblastoma Endocrine Practice Vol 10 No. 2 March/April 2004 5. Melmed, Shlomo, et al. Williams textbook of endocrinology. Elsevier Health Sciences, 2015.